The epigenetic regulators CBP and p300 facilitate leukemogenesis and represent therapeutic targets in acute myeloid leukemia. (2016)

First Author: Giotopoulos G
Attributed to:  Wellcome Trust MRC Cambridge Stem Cell Institute funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/onc.2015.92

PubMed Identifier: 25893291

Publication URI: http://europepmc.org/abstract/MED/25893291

Type: Journal Article/Review

Volume: 35

Parent Publication: Oncogene

Issue: 3

ISSN: 0950-9232